Durability of Antiplatelet Effect of a Novel Extended-Release Formulation of Acetylsalicylic Acid, Durlaza, in Patients with Diabetes

被引：0
|
作者：
Patrick, Jeff [2 ]
Bliden, Kevin [1 ]
Tantry, Udaya [1 ]
Pennell, Andrew [2 ]
Gurbel, Paul [1 ]
机构：
[1] Inova Heart & Vasc Inst, Falls Church, VA USA
[2] New Haven Pharmaceut Inc, North Haven, CT USA
来源：
NEUROLOGY | 2016年 / 86卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P5.212
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Superior efficacy of clopidogrel plus acetylsalicylic acid compared with extended-release dipyridamole plus acetylsalicylic acid in preventing arterial thrombogenesis in healthy volunteers
    Cadroy, Y
    Thalamas, C
    Sakariassen, K
    Boneu, B
    THROMBOSIS RESEARCH, 2005, 116 (04) : 293 - 300
  • [22] Safety and efficacy of a novel extended release formulation of metformin in patients with type 2 diabetes
    Raz, I
    Delaet, I
    Goyvaerts, H
    Swanink, R
    Stein, P
    DIABETES, 2000, 49 : A363 - A363
  • [23] Evaluation of the durability of pain relief throughout a 12 hour dosing interval of a novel, extended-release, abuse-deterrent formulation of oxycodone
    Nalamachu, Srinivas
    Kopecky, Ernest A.
    Taylor, Robert, Jr.
    Vaughn, Ben
    O'Connor, Melinda
    CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (07) : 1311 - 1317
  • [24] Safety and tolerability of extended-release acetylsalicylic acid capsules: a summary of double-blind comparative studies
    Patrick, Jeff
    Johnson, Andrew
    Dillaha, Larry
    Pennell, Andrew T.
    FUTURE CARDIOLOGY, 2016, 12 (06) : 627 - 638
  • [25] Advantages of Extended-Release Metformin in Patients with Type 2 Diabetes Mellitus
    Jabbour, Serge
    Ziring, Barry
    POSTGRADUATE MEDICINE, 2011, 123 (01) : 15 - 23
  • [26] Novel extended-release carbamazepine oral suspension: Formulation, evaluation and drug-release kinetic study
    Alsammarraie, Harith Jameel Mahdi
    Al-Abasi, Menaa Abdulsalam
    Mohammad, Adnan Majeed
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 37 (06) : 1615 - 1624
  • [27] Novel pharmacokinetic-pharmacodynamic model for prediction of outcomes with an extended-release formulation of ciprofloxacin
    Meagher, AK
    Forrest, A
    Dalhoff, A
    Stass, H
    Schentag, JJ
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (06) : 2061 - 2068
  • [28] Syringeability of morphine ARER, a novel, abuse-deterrent, extended-release morphine formulation
    Kinzler, Eric R.
    Pantaleon, Carmela
    Iverson, Matthew S.
    Aigner, Stefan
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2019, 45 (04): : 377 - 384
  • [29] Patient adherence to and tolerability of treatment with metformin extended-release formulation in patients with type 2 diabetes. GLUCOMP study
    Strojek, Krzysztof
    Kurzeja, Anna
    Gottwald-Hostalek, Ulrike
    CLINICAL DIABETOLOGY, 2016, 5 (01): : 15 - 21
  • [30] Pharmacokinetics and Pharmacodynamics of the Antiplatelet Combination Aspirin (Acetylsalicylic Acid) Plus Extended-Release Dipyridamole Are Not Altered by Coadministration with the Potent CYP2C19 Inhibitor Omeprazole
    Elliot Offman
    Michael J. Schobelock
    Rolf Brickl
    Cam P. VanderMaelen
    Jerome Ehrlich
    Wolfgang Eisert
    American Journal of Cardiovascular Drugs, 2013, 13 : 113 - 120
12345